WO2018017617A1 - Procédés et appareils d'analyse de concentration de substance - Google Patents

Procédés et appareils d'analyse de concentration de substance Download PDF

Info

Publication number
WO2018017617A1
WO2018017617A1 PCT/US2017/042675 US2017042675W WO2018017617A1 WO 2018017617 A1 WO2018017617 A1 WO 2018017617A1 US 2017042675 W US2017042675 W US 2017042675W WO 2018017617 A1 WO2018017617 A1 WO 2018017617A1
Authority
WO
WIPO (PCT)
Prior art keywords
mir
temperature
calculating
substance
measured
Prior art date
Application number
PCT/US2017/042675
Other languages
English (en)
Inventor
Yonatan Gerlitz
Efraim LANDA
Alexander Ostritsky
Original Assignee
Glucovista Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glucovista Inc. filed Critical Glucovista Inc.
Priority to EP17751514.5A priority Critical patent/EP3484365B1/fr
Priority to CN201780046715.2A priority patent/CN109561857B/zh
Priority claimed from US15/653,428 external-priority patent/US10588552B2/en
Publication of WO2018017617A1 publication Critical patent/WO2018017617A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1491—Heated applicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0406—Constructional details of apparatus specially shaped apparatus housings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms

Definitions

  • Spectroscopic techniques using infrared ("IR") radiation are known in the prior art and have been widely used for non-invasive measurement of the concentration of substances of interest in a body.
  • IR infrared
  • One area of particular interest is the use of these techniques for the non-invasive measurement of the concentration of glucose and other constituents of the human bloodstream.
  • Several patents and patent applications disclose methods to non-invasively measure the
  • concentration of a substance such as glucose, for example, in the bloodstream using infrared detection systems and methods.
  • U.S. Patent Application No. 12/883,063, filed September 15, 2010 and entitled "Method for non-invasive analysis of a substance concentration within a body,” describes methods of measuring a concentration of a substance, such as glucose, in a body.
  • the described methods include changing the temperature of the surface of a body from a first temperature to a second temperature, then changing the temperature of the surface of the body from the second temperature back to the first temperature.
  • the method includes measuring a first amount of infrared (“IR”) radiation absorbed by or emitted from the surface of the body in a first wavelength band and a second amount of IR radiation absorbed by or emitted from the surface of the body in a second wavelength band at predetermined time intervals.
  • IR infrared
  • the measurements occur during the time period that the temperature of the surface of the body changes from the second temperature back to the first temperature.
  • a concentration of the substance may be determined based on the measurements.
  • One substance concentration analysis method includes calculating a dT/dt value for a particular time for a temperature derivative with respect to time (dT/dt) of a function for a measured surface temperature (T) of a body that varies with time (t), calculating a difference for the particular time between a first measured amount of mid-infrared (MIR) radiation absorbed by or emitted from a body in a first wavelength and a second measured amount of MIR radiation absorbed by or emitted from the body in a second wavelength, calculating a quotient including a dividend based on the difference divided by a divisor based on the dT/dt value, and calculating the concentration of the substance in the body based on a correlation with the quotient and outputting the concentration to a user.
  • MIR mid-infrared
  • Another substance concentration analysis method includes inducing a change in a temperature (T) of a surface of a body over time (t) by heating or cooling with an element according to a signal received by the element, then allowing temperature recovery of the surface and yielding a function for temperature (T) that varies with time (t) during the temperature recovery so as to exhibit a temperature derivative with respect to time (dT/dt).
  • the method includes measuring the temperature (T) of the surface of the body over time (t) during the temperature recovery and calculating the dT/dt, measuring mid-infrared (MIR) radiation absorbed by or emitted from the body during the temperature recovery while the surface of the body exhibits the dT/dt, calculating a measured value based on the MIR radiation measurement and on the dT/dt, and calculating the concentration of the substance in the body based on a correlation with the measured value.
  • T temperature
  • MIR mid-infrared
  • One substance concentration analysis apparatus configured to implement any of the methods herein includes a housing, at least one MIR detector attached to the housing, a ring-shaped heating and/or cooling element attached to the housing, a processor controlling the MIR detector and the ring-shaped heating and/or cooling element, and a transmission window structure in direct thermal communication with the ring-shaped heating and/or cooling element and attached to the housing such that a line of sight of the MIR detector passes through the transmission window structure.
  • Another substance concentration analysis apparatus includes a housing, at least one MIR detector attached to the housing, a ring-shaped heating and/or cooling element attached to the housing, and a thermally conductive ring in thermal communication with the ring-shaped heating and/or cooling element.
  • the apparatus includes a transmission window structure attached to the housing such that a line of sight of the MIR detector passes through the transmission window structure, a surface of the transmission window structure, and a surface of the thermally conductive ring being aligned along a same plane outside the housing.
  • FIG. 1 a block diagram of an embodiment of a wearable system for continuously monitoring a concentration of a substance in a body is depicted and generally designated 100.
  • FIG. 2 an embodiment of a system for continuously monitoring a concentration of a substance in a body is depicted and generally designated 200.
  • FIG. 3 an embodiment of a detection configuration is depicted and generally designated 300.
  • FIG. 4 an embodiment of a heating and/or cooling window assembly is depicted and generally designated 400.
  • FIG. 5 an embodiment of a system for continuously monitoring a concentration of a substance in a body is depicted and generally designated 500.
  • FIG. 6 an embodiment of another window assembly for the system of FIG. 5 is depicted and generally designated 600.
  • FIGS. 7A and 7B an embodiment of periodic signals and corresponding periodic temperature changes are depicted.
  • FIG. 8 a hypothetical graph is shown of a ratio of two signals in a first wavelength with glucose emission/absorption and a second wavelength with no, or marginal, glucose emission/absorption versus dT/dt.
  • the monitoring may occur continuously or non-continuously.
  • the embodiments described herein may be used to continuously monitor a concentration of glucose in a person's blood. Some of the embodiments described herein may be worn for periods of time that range from several minutes to days.
  • the embodiments herein may be used to analyze a concentration of glucose in a person's blood at a particular time.
  • the infrared measurements may be taken in the mid infrared (MIR) range, where infrared spectra exhibit wavelengths of about 6 to about 15 micrometers ( ⁇ ).
  • MIR mid infrared
  • emission/absorption signal is also proportional to dT/dt.
  • dT/dt The relationship between dT/dt and the ratio or difference may be described with a function for dT/dt (see FIG. 8).
  • the existence of the function thus permits statistically smoothing measured ratio or difference values before correlating the ratio or difference to the blood glucose concentration level.
  • Known algorithms for smoothing data may be applied to data points containing a ratio or difference value and a dT/dt value calculated from measurements. Possible examples include algorithms provided in EXCEL available from Microsoft Corp. in Kirkland, Washington and provided in MATLAB available from The MathWorks, Inc. in Natick, Massachusetts. Utilizing this correction increases accuracy of the correlation of the ratio or difference to the blood glucose concentration level.
  • the system 100 may include a controller 1 10, a power source 122, a display device 124, a wireless transmitter 126, a mid- infrared (MIR) detector assembly 130, a heating and/or cooling window assembly 150, and an attachment mechanism 170.
  • the MIR detector 130 may include a preassembled sensor and an optical element (not shown).
  • the optical element may include a lens, and may focus raw IR radiation on the sensor in order to detect the radiation.
  • the optical element may be a window.
  • the controller may include a processor 1 12 and a memory 1 14.
  • the processor 1 12 may include any circuitry capable of receiving and processing data.
  • the processor 1 12 may include a microprocessor, a microcontroller, a peripheral interface controller (PIC), a digital signal processor (DSP), another type of processing element, or any combination thereof.
  • PIC peripheral interface controller
  • DSP digital signal processor
  • the memory 1 14 may include one or more registers, cache memory, random access memory (RAM), read only memory (ROM), solid state memory, magnetic disc memory, another type of volatile or non-volatile memory, or any combination thereof.
  • processor 112 and the memory 1 14 may be implemented using circuit logic, an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), another type of circuit implementation platform, or any combination thereof.
  • ASIC application specific integrated circuit
  • FPGA field programmable gate array
  • the memory 1 14 may be accessible to the processor 1 12 to enable the processor 1 12 to retrieve data from the memory 1 14 and to store data at the memory 1 14.
  • the memory 1 14 may include a processor readable medium that may store instructions that, when executed by the processor, cause the processor to perform operations as described herein.
  • the power source 122 may provide power to the controller 1 10, the display device 124, the wireless transmitter 126, the MIR detector assembly 130, the heating and/or cooling window assembly 150, or to any subset thereof.
  • the power source 122 may be lightweight and portable to enable the system 100 to be worn on a body without restricting movement of the body.
  • the power source 122 may further hold a charge for extended durations to enable long term portability.
  • the power source 122 may be capable of powering the system 100 for one or more days without being recharged.
  • the power source 122 includes a rechargeable lithium ion battery pack.
  • the display device 124 may include any device capable of outputting visual or audio signals to a user of the system 100.
  • the display device may include a liquid crystal diode (LCD) screen, a buzzer, another type of visual or audio output device, or any combination thereof.
  • FIG. 1 depicts the system 100 as including the display device 124, in some embodiments, the system 100 may omit the display device 124.
  • the system 100 may omit the display device 124.
  • the display device 124 may include any device capable of outputting visual or audio signals to a user of the system 100.
  • the display device may include a liquid crystal diode (LCD) screen, a buzzer, another type of visual or audio output device, or any combination thereof.
  • the system 100 may rely on a wireless transmission to a remote device to generate user outputs.
  • the wireless transmitter 126 may include any device capable of transmitting information to a remote device.
  • the remote device may include a mobile telephone, a portable music player, a tablet computer, a laptop computer, another type of computing device, or combinations thereof.
  • the wireless transmitter may communicate with the remote device via a network.
  • the network may include a point-to-point network, a cellular network, a local area network, a wide area network, another type of digital network, or combinations thereof.
  • FIG. 1 depicts the system 100 as including the wireless transmitter 126, in some embodiments, the system 100 may omit the wireless transmitter 126. As an example, in some embodiments, the system 100 may rely on the display device 124 to generate user outputs instead of the wireless transmitter 126.
  • the MIR detector assembly 130 may include devices capable of detecting MIR emission and/or absorption within one or more wavelength bands.
  • the MIR detector assembly 130 may detect MIR emission and/or absorption in a first wavelength band where a substance of interest, e.g., glucose, affects the MIR emission and/or absorption and may also detect MIR emission and/or absorption in a second wavelength band where the substance of interest has no or negligible effect on the MIR emission and/or absorption.
  • the first wavelength band may be referred to as a peak wavelength band and the second wavelength band may be referred to as a reference wavelength band.
  • the first wavelength band may be about 9.3 ⁇ to about 9.9 um.
  • the second wavelength band may be about 10.5 ⁇ to about 15 ⁇ .
  • the MIR detector assembly 130 may be further configured to measure the MIR emission and/or absorption of one or more blackbody devices, as described further herein. Embodiments of the MIR detector assembly 130 are described further herein.
  • the heating and/or cooling window assembly 150 may include devices for heating and/or cooling.
  • the heating and/or cooling window assembly 150 may also include at least one surface that is transparent to MIR radiation to pass the MIR radiation from a body to the MIR detector assembly 130. Passing the MIR radiation may occur at the same time that heating and/or cooling is performed. An embodiment of the heating and/or cooling assembly 150 is further described herein.
  • the attachment mechanism 170 may include any mechanism capable of attaching one or more components of the system 100 to a body.
  • the attachment mechanism may include a buckle, a hook and loop fastener, a snap, another type of attachment device, or combinations thereof.
  • the attachment mechanism 170 may enable the contact to remain for long durations so the system 100 may be worn on the body.
  • the system 100 may continue to be worn on a body for an extended duration of time. For example, the system 100 may be worn for more than 30 minutes, more than one hour, more than 5 hours, or for one or more days. During the duration of time, the attachment mechanism 170 may hold the heating and/or cooling window assembly 150 in contact with the body.
  • the MIR detector assembly 130 may take or otherwise generate a plurality of MIR measurement sets over the duration of time that the system 100 is worn on the body.
  • the plurality of MIR measurements may be taken without removing the wearable apparatus from the body.
  • Each MIR measurement set may include a first MIR measurement of the body at the peak wavelength band, where a substance of interest has an effect on MIR emission and/or absorption, and a second MIR measurement at a reference wavelength band, where the substance has no or negligible effect on MIR emission and/or absorption.
  • each measurement set may further include a MIR measurement of one or more blackbody devices within one or both of the wavelength bands.
  • the MIR measurement sets may be taken through the heating and/or cooling window assembly 150.
  • MIR radiation from the body may pass through a portion of the heating and/or cooling window assembly to the MIR detector assembly 130 to be measured.
  • the heating and/or cooling window assembly may heat and or cool a surface of the body.
  • the heating and/or cooling window assembly may change a temperature of the body according to a periodic signal received from the controller 1 10.
  • Each measurement set taken by the system 100 may correspond to a respective period of the periodic signal. Further, each measurement set may be taken during a portion of the periodic signal where the rate of change in temperature of the heating and/or cooling window assembly or of the surface the body is constant. In some embodiments, a period of the periodic signal is about 60 seconds.
  • the periodic signal may be configured to produce a periodic temperature pattern that correspond to a square wave, a triangle wave, a sinusoidal wave, or combinations thereof. Examples of the periodic signal and a resulting periodic change in temperature are described further with reference to FIGS. 7A and 7B.
  • FIGS. 7A and 7B an embodiment of periodic signals and corresponding periodic temperature changes are depicted.
  • FIG. 7A depicts a square signal wave 810.
  • the square signal wave 810 When the square signal wave 810 is applied to a heating and/or cooling device, it may result in a sinusoidal temperature wave 820 at the surface of the body.
  • FIG. 7B depicts a signal wave 830.
  • the signal wave 830 When the signal wave 830 is applied to a heating and/or cooling device, it may result in a triangular temperature wave 840 at the surface of the body.
  • Measurement sets, as described herein may advantageously be taken during portions of the triangular temperature fluctuation 840 that exhibit a substantially constant rate of temperature change. For example, measurements may be taken when the slope of the triangular temperature fluctuation, such as dT/dt, is approximately constant or, preferably, actually constant.
  • a measurement may be taken during a positive dT/dt (where the temperature has a positive slope over time) and another measurement may be taken during a negative dT/dt (where the temperature has a negative slope over time) at the same temperature T.
  • the measurements may be used to isolate a part of the measurement that is f(dT/dt), which corresponds to the glucose emission/absorption band.
  • MIR radiation emitted from the human body has two major contributors to the MIR signal measured in a band where glucose has peak emission/absorption.
  • First is the normal black body emission which is correlated to the 4th power of temperature (T 4 ).
  • the second contributor is glucose spectral emission/absorption. In cases where the measured volume is approximately in thermal equilibrium, the glucose emission/absorption will approach zero, due to the fact that in thermal equilibrium the number of molecules that emit photons will be close to the number of molecules that absorb photons.
  • M is a measured signal
  • BB r is a Black Body radiation
  • f(dT/dt) is a function of the temperature derivative over time
  • f(N) is a function of the number of glucose molecules in the measured volume
  • k is a constant
  • p is a perturbation, emission or absorption of other substances.
  • V is a measured volume that is a constant of the apparatus used and C is the concentration of glucose in this volume (for example, corresponding to tissue at a particular test site of the body).
  • C is the concentration of glucose in this volume (for example, corresponding to tissue at a particular test site of the body).
  • C concentration of glucose in this volume
  • f(dT/dt) is normalized such that it will be between 0 and 1, which will represent the relative number of molecules that we take out of Boltzmann equilibrium (based on the Boltzmann equation).
  • the Boltzmann equation may describe the change of a macroscopic quantity in a thermodynamic system. Being removed from Boltzmann equilibrium may alter the emission and/or absorption of the molecules and, as such, may have an impact on the macroscopic emission and/or absorption of the body.
  • These molecules will be the population that emits or absorbs photons (depending on the stimulation) and will be a fraction of the total number of molecules (C).
  • the measured volume may be alternately stimulated with heating and cooling.
  • the measured volume may be stimulated in one direction and then emission/absorption measured as the volume returns to thermal equilibrium.
  • M2 BB R - kl * f (— ) * /(C) ⁇ p ⁇ k (Equation 5) when the volume is being heated.
  • the device also measures radiation in a reference band (where emission/absorption is negligible for glucose). Using the equation above and a value of 0 for f(C) (because no glucose signal is being emitted) we can subtract two reference measurements at the same temperature to obtain the following equation:
  • p 1 p2 if all the other material in the measured volume that emits radiation in both wave bands has a flat emission spectrum, which means that the emission or absorption in both wavelengths will be the same as long as dT/dt is kept constant, that is, as long as dT/dt has the same absolute value at the same temperature. [0047] We can then use the combination of the two peak glucose measurements and the combination of the reference glucose measurements to obtain the following formula for a measured value (assuming we measure at the same temperature and keep dT/dt constant across all
  • kl is a constant
  • f(dT/dt) is a factor for how much the measured volume is stimulated
  • f(C) is a function for how many glucose molecules are in the measured volume.
  • the formula may be divided by f(dT/dt) such that f(dT/dt) becomes the denominator in the measured value.
  • dT/dt at the time of MIR measurement may be included in the measured value
  • Equation 8 may be rewritten as follows: f(C) (Equat
  • a slope value 2*kl*f(dT/dt) may be considered an x value of a data point and (Ml - M2) - (Rl - R2) may be considered a y value of the data point.
  • a best fit data analysis may generate a slope for the (x,y) values. Based on Equation 9, the resulting slope value may be correlated to C For example, C may be correlated to the actual concentration of the substance in the blood.
  • the controller 110 may generate a consecutive plurality of data parameters indicative of respective concentrations of a substance in the body based on the corresponding plurality of MIR measurement sets as described herein.
  • the plurality of data parameters may then be stored.
  • the plurality of data parameters may be stored at the memory 114, or at another memory of the system 100.
  • continuous monitoring refers to measuring substance concentration over time while the monitoring apparatus continues to contact the body between consecutive measurements. That is, even though the monitoring apparatus may be programmed to take a measurement at periodic intervals, any interval may be selected.
  • the monitoring apparatus is capable of taking a measurement at any time since it is not removed from contact with the body between consecutive measurements. An operator may program a selected measurement interval. Also, the monitoring apparatus may automatically change measurement intervals, depending on programmed conditions. For example, more frequent measurement may be warranted when concentration approaches a level of concern.
  • the concentration of the substance within the body may be continuously monitored by determining whether the substance concentrations or the consecutive plurality of data parameters are within a tolerance. For example, as new data parameters indicative of the concentration of the substance are generated at the processor 112, the new data parameters may be compared to one or more tolerances. Alternatively or additionally, the concentrations may be compared to one or more tolerances. The tolerances may be stored at the memory 114 or elsewhere in the system 100. If the new data parameter or concentration is outside the tolerance, such as less than a lower tolerance or greater than an upper tolerance, a warning output may be generated and sent to the display device. Alternatively or in addition, the warning output may be sent to the wireless transmitter.
  • the wireless transmitter may be configured to send the warning output to a remote device.
  • the remote device may include a cellular telephone, a tablet, a laptop, or another type of mobile computing device.
  • the warning output may indicate to the remote device to display a warning.
  • the warning output may further indicate to the mobile device to contact an emergency service.
  • the processor 112 may calculate a continuous correlation function. Thereafter, the processor 112 may modify at least one of the plurality of data parameters based on the continuous correlation function. For example, as the processor 112 generates new data parameters indicative of a concentration of the substance in the body, the processor 112 may adjust or otherwise modify the new data parameters based on the continuous correlation function.
  • the processor 112 may adjust or modify individual raw MIR measurements as they are received from the MIR detector assembly 130 and use the modified MIR measurements in generating new data parameters indicative of a concentration of the substance.
  • the continuous correlation function may reduce noise and/or measurement variations in the plurality of MIR measurement sets.
  • the continuous correlation function may correlate between the
  • the function parameters are calibrated for each person.
  • the function may be a polynomial, such as:
  • Results may be normalized against a blackbody with predetermined specifications and corrected for ambient temperature.
  • the parameters of a - e are determined from a set of calibration measurements.
  • VN the noise in the correlation function that limits its accuracy
  • some embodiments may make use of the parameter of maximum change rate of glucose concentration in human body, which is 4 mg/dL/min. In some embodiments, measurements may be taken every 3 seconds, which means that the maximum change between adjacent measurements of glucose may be less than 0.2 mg/dL.
  • a substance concentration monitoring method includes inducing a periodic change in a temperature (T) of a surface of a body over time (t) using a heating and/or cooling element according to a periodic signal received by the element and yielding a function for temperature (T) that varies with time (t) so as to exhibit a temperature derivative with respect to time (dT/dt) that oscillates periodically.
  • Mid-infrared (MIR) radiation absorbed by or emitted from the body is measured while the surface of the body exhibits the oscillating, periodic dT/dt.
  • the method includes determining a measured value based on the MIR radiation measurements and determining a concentration of a substance in the body based on a correlation with the measured value.
  • the measured value may also be based on the oscillating, periodic dT/dt. Further, the measured value may be correlated with glucose concentration. Measuring IR radiation may include measuring the MIR radiation at a temperature during a positive dT/dt (an upward sloping temperature change) and measuring the MIR radiation at the same temperature during a negative dT/dt (a downward sloping temperature change).
  • the measurement of IR radiation may include measuring a first MIR radiation at a temperature during a positive dT/dt (an upward sloping temperature change), the measuring occurring within a first wavelength band in which the substance has an effect on MIR emission or absorption.
  • the measurement of IR radiation may also include measuring a first reference MIR radiation at the temperature during the positive dT/dt, the measuring occurring within a second wavelength band in which the substance has no or negligible effect on MIR emission or absorption.
  • the measurement of IR radiation may further include measuring a second MIR radiation at the temperature during a negative dT/dt (a downward sloping temperature change), the measuring occurring within the first wavelength band.
  • the measurement of IR radiation may still further include measuring a second reference IR radiation at the temperature during the negative dT/dt, the measuring occurring within the second wavelength band.
  • determining the measured value may include the first and second MIR radiation measurements and the first and second reference MIR radiation measurements in an equation that yields the measured value.
  • the method may further include generating a correlation of the measured value with the substance concentration. For example, a correlation to invasively measured blood concentrations. Also, dT/dt may be determined at the time the MIR radiation is measured and dT/dt may be included in the measured value that is correlated with the substance concentration.
  • the present method or a similar method may be implemented with a substance concentration monitoring apparatus.
  • the apparatus may include a processor, a heating and/or cooling element, an infrared sensor, and a memory accessible to the processor.
  • the memory stores instructions that, when executed by the processor, cause the processor to initiate operations including generating a periodic signal configured to control the heating and/or cooling element and thereby to induce a periodic change in a temperature (T) of a surface of a body over time (t) and to yield a function for temperature (T) that varies with time (t) so as to exhibit a temperature derivative with respect to time (dT/dt) that oscillates periodically.
  • the instructions include collecting data from the infrared sensor while the surface of the body exhibits the oscillating, periodic dT/dt.
  • the data results from a measurement of mid-infrared (MIR) radiation absorbed by or emitted from the body within a first wavelength band in which a substance has an effect on MIR emission or absorption and a measurement of MIR reference radiation absorbed by or emitted from the body within a second wavelength band in which the substance has no or negligible effect on MIR emission or absorption.
  • the instructions include determining a measured value based on the MIR radiation data and the MIR reference radiation data and determining a concentration of the substance in the body based on a correlation with the measured value.
  • the processor operations may further include monitoring the concentration of the substance in the body by determining whether the concentration or the measured value are within a tolerance and generating a warning output when the concentration or the measured value is outside the tolerance.
  • the apparatus may further include a wireless transmitter and the processor operations may further include sending the warning output to a remote device via the wireless transmitter to display a warning.
  • the remote device may include a mobile telephone and the warning output may indicate that the remote device is to contact an emergency service.
  • the measured value may be additionally based on the oscillating, periodic dT/dt.
  • the measured value may be correlated with glucose concentration.
  • the periodic signal may be configured to produce a constant rate of change in temperature (dT/dt) of the heating and/or cooling element during both the positive and the negative dT/dt.
  • collecting the data may further include determining dT/dt at the time the MIR radiation is measured and determining the measured value may further involve including dT/dt in the measured value that is correlated with the substance concentration.
  • the periodic signal may be configured to produce a periodic temperature pattern of the heating and/or cooling element that corresponds to a square wave, a triangle wave, a sinusoidal wave, or a combination thereof.
  • the measured volume may be stimulated in one direction and then emission/absorption measured as the volume returns to thermal equilibrium. That is, the radiation measurement may be non-continuous since it does not occur during both heating and cooling.
  • the measured signal in the band where glucose is present as follows with an expression similar to Equation 3:
  • M is the measured signal in the band with glucose
  • f(dT/dt) is a function that gives the fraction of glucose molecules between 0 and 1 that will emit or absorb photons when taken out of Boltzmann equilibrium when the rate of temperature change is dT/dt;
  • f(C) is the quantity of glucose molecules in the measured volume that we want to correlate with the blood glucose as measured by the known gold standard; p is the emission of other materials in the sample volume that are also a function of dT/dt; and kl and k are constants.
  • Equation 1 1 for a measured signal (M) during heating of skin, which may include rewarming of skin after being cooled, provides:
  • Equation 13 Equation 13
  • Equation 15 when all measurements are normalized to black body calibration and corrected for ambient temperature effects on measurement apparatuses, is correlated with the gold standard for blood glucose.
  • TGS as described in Sterling, is based on measurement during cooling of the skin, while one method herein relies on measurement during natural recovery of skin temperature after cooling (i.e. while the skin is warming). That method herein relies on thermal emission from the upper layer of skin while Sterling relies on the upper layer to be transparent to emission from deeper layers in the skin. In Sterling, heating only happens to enable another cooling cycle.
  • the measurement cycle in Sterling lasts 0.2 seconds, allowing only one measurement per thermal cycle, while a measurement cycle herein can last up to one minute or more enabling multiple measurements during a thermal cycle. This gives the ability to smooth the data collected in a measurement cycle, resulting in more reliable measurement of concentrations over time.
  • the version of dT/dt herein is longer.
  • One substance concentration analysis method includes calculating a dT/dt value for a particular time for a temperature derivative with respect to time (dT/dt) of a function for a measured surface temperature (T) of a body that varies with time (t), calculating a difference for the particular time between a first measured amount of mid-infrared (MIR) radiation absorbed by or emitted from a body in a first wavelength and a second measured amount of MIR radiation absorbed by or emitted from the body in a second wavelength, calculating a quotient including a dividend based on the difference divided by a divisor based on the dT/dt value, and calculating the concentration of the substance in the body based on a correlation with the quotient and outputting the concentration to a user.
  • MIR mid-infrared
  • the quotient may be correlated with glucose concentration.
  • the divisor may be a value of a function of dT/dt (f(dT/dt)) that yields a fraction of the substance concentration between 0 and 1 that emits or absorbs photons when taken out of Boltzmann equilibrium at the dT/dt value.
  • the calculation of the quotient may include calculating a slope value for a series of (x,y) values in which x values are the divisor and y values are the dividend measured over time while the surface exhibits the dT/dt.
  • the method may further include measuring the first measured amount of MIR radiation absorbed by or emitted from the body in the first wavelength at the particular time, measuring the second measured amount of MIR radiation absorbed by or emitted from the body in the second wavelength at the particular time, and measuring the measured surface temperature at the particular time.
  • the substance may have an effect on MIR emission or absorption in the first wavelength and have no or negligible effect on MIR emission or absorption in the second wavelength. Measuring the first measured amount, the second measured amount, and the measured surface temperature may occur during a positive dT/dt (an upward sloping temperature change).
  • the method may further include normalizing the first measured amount and the second measured amount to black body calibration, measuring an ambient temperature at the particular time, and correcting the quotient for ambient temperature effects on a measurement apparatus for the ambient temperature.
  • Calculating the dT/dt value for the particular time may include measuring the measured surface temperature at each of a plurality of different times including the particular time, curve- fitting the corresponding plurality of measured surface temperatures to obtain the function for temperature (T) of the surface of the body that varies with time (t), including the particular time, differentiating the function for temperature (T) to obtain the temperature derivative with respect to time (dT/dt), and calculating the dT/dt value by evaluating the dT/dt for the particular time.
  • the method may further include generating a correlation of the substance concentration with the quotient by, for each of a plurality of different times, calculating the dT/dt value and calculating the difference.
  • the method includes statistically smoothing the plurality of differences for the corresponding plurality of dT/dt values to correct the plurality of differences and providing a function of dT/dt (f(dT/dt)) that yields a fraction of the substance concentration between 0 and 1 that emits or absorbs photons when taken out of Boltzmann equilibrium.
  • the method includes calculating a f(dT/dt) value by evaluating the f(dT/dt) for the respective dT/dt value and calculating the quotient with the corresponding f(dT/dt) value as the divisor.
  • the method includes correlating the concentration of the substance in the body with the plurality of quotients.
  • Another substance concentration analysis method includes inducing a change in a temperature (T) of a surface of a body over time (t) by heating or cooling with an element according to a signal received by the element, then allowing temperature recovery of the surface and yielding a function for temperature (T) that varies with time (t) during the temperature recovery so as to exhibit a temperature derivative with respect to time (dT/dt).
  • the method includes measuring the temperature (T) of the surface of the body over time (t) during the temperature recovery and calculating the dT/dt, measuring mid-infrared (MIR) radiation absorbed by or emitted from the body during the temperature recovery while the surface of the body exhibits the dT/dt, calculating a measured value based on the MIR radiation measurement and on the dT/dt, and calculating the concentration of the substance in the body based on a correlation with the measured value.
  • T temperature
  • MIR mid-infrared
  • the present method may include the features of the other methods herein.
  • the method may include calculating a dT/dt value for the time the MIR radiation is measured.
  • the allowing of temperature recovery of the surface may occur without the heating or cooling of the element.
  • the measured value may be correlated with glucose concentration.
  • Measuring MIR radiation may include measuring MIR radiation during a positive dT/dt (an upward sloping temperature change), the measuring occurring within a first wavelength band in which the substance has an effect on MIR emission and measuring reference MIR radiation at the temperature during the positive dT/dt, the measuring occurring within a second wavelength band in which the substance has no or negligible effect on MIR emission.
  • a positive dT/dt an upward sloping temperature change
  • One substance concentration analysis apparatus configured to implement any of the methods herein includes a housing, at least one MIR detector attached to the housing, a ring-shaped heating and/or cooling element attached to the housing, a processor controlling the MIR detector and the ring-shaped heating and/or cooling element, and a transmission window structure in direct thermal communication with the ring-shaped heating and/or cooling element and attached to the housing such that a line of sight of the MIR detector passes through the transmission window structure.
  • present apparatus may include the features discussed herein for other apparatuses.
  • the transmission window structure may exhibit a thermal conductivity greater than 1,000 Watts/meter-Kelvin (W/m-K). While germanium and aluminum discussed above exhibit thermal conductivities of about 50 and 180 W/m-K, respectively, chemical vapor deposited diamond (CVDD) exhibits a thermal conductivity of about 1,800 W/m-K.
  • CVDD chemical vapor deposited diamond
  • FIG. 2 an embodiment of a system for continuously or non-continuously monitoring a concentration of a substance in a body is depicted and generally designated 200.
  • the system 200 includes one or more printed circuit boards (PCBs) 210, a housing 220, a battery 222, a first MIR detector 230, a second MIR detector 231, a dichroic beam splitter 234, and a heating and/or cooling window assembly 250.
  • the system 200 may correspond to an apparatus for measuring the concentration of glucose within a body.
  • the housing 220 may hold the MIR detectors 230-231 and the dichroic beam splitter 234 together in a detection configuration. As such, the housing 220 may serve as an accurate mechanical reference for the positioning of the MIR detectors 230, 231 and the dichroic beam splitter 234.
  • the housing 220 may further be made of a material that conducts heat in order to serve as a heat sink to stabilize the temperatures of the components of the system 200.
  • the housing 220 may be made of aluminum or an aluminum alloy.
  • the first MIR detector 230 and/or the second MIR detector 231 may include a preassembled sensor and an optical element (not shown).
  • the optical element may include a lens, and may focus raw IR radiation on the sensor in order to detect the radiation.
  • the optical element may be a window.
  • the one or more PCBs 210 may include pre-amplifiers, microprocessors, transmitters, receivers, and any other electrical components to implement a controller, e.g., the controller 1 10.
  • the power source 222 may include a rechargeable lithium ion type battery and may be positioned near the edge of the system 200 to enable easy access for replacement.
  • the heating and/or cooling window assembly 250 may correspond to the heating and/or cooling window assembly 150 and is further described with reference to FIG. 4.
  • FIG. 3 an embodiment of a detection configuration is depicted and generally designated 300.
  • FIG. 3 illustrates the configuration of the first MIR detector 230, the second MIR detector 231, and the dichroic beam splitter 234.
  • the first MIR detector 230 and the second MIR detector may include thermopile detectors to detect light within the MIR spectrum.
  • the first MIR detector 230 may receive IR radiation through the dichroic beam splitter 234 from a measurement area 280.
  • the second MIR detector 231 may receive the same IR radiation through the dichroic beam splitter 234.
  • Both the MIR detectors 230, 231 have a combined field of view after the dichroic beam splitter 234.
  • both the MIR detectors 230, 231 receive radiation from the same measurement area 280.
  • the first MIR detector 230 may be configured to detect MIR radiation in a first wavelength band (e.g., a peak band).
  • the second MIR detector 231 may be configured to detect MIR radiation in a second wavelength band (e.g., a reference band).
  • a heating and/or cooling window assembly is depicted and generally designated 400.
  • the assembly 400 includes a transmission window structure 452, a thermally conductive ring 454, and a heating and/or cooling element 456.
  • the heating and/or cooling element 456 may be ring-shaped and may be attached to the thermally conductive ring 454.
  • a thermally conductive adhesive is used to attach the heating and/or cooling element 456 to the thermally conductive ring 454.
  • the heating and/or cooling element 456 is a Peltier element.
  • the thermally conductive ring 454 may be thicker than the heating and/or cooling element 456 so the internal radius of the thermally conductive ring 454 may be smaller than the internal radius of the heating and/or cooling element 456.
  • the thermally conductive ring 454 includes aluminum or an aluminum alloy.
  • the transmission window structure 452 may be attached to the inside of the thermally conductive ring 454. Additionally, the transmission window structure 452 may have an outer down step ring to enable a surface 408 of the thermally conductive ring 454 to be aligned and maintain alignment with a surface 409 of the transmission window structure 452 along a single plane outside the housing 220.
  • the surfaces 408, 409 may contact a surface of a body.
  • the transmission window structure is made of a material that is substantially transparent to light within the MIR range.
  • the transmission window structure may include germanium, silicon, or both.
  • the heating and/or cooling window assembly 400 may correspond to the assembly 250 and may, in some embodiments, be attached to the housing 220.
  • the heating and/or cooling element 456, the thermally conductive ring 454, or both may be attached to the housing 220.
  • the transmission window structure 452 When attached to the housing, the transmission window structure 452 may be positioned such that a line of sight of the MIR detectors 230, 231 passes through the transmission window structure 452.
  • FIG. 5 an embodiment of a system for continuously or non-continuously monitoring a concentration of a substance in a body is depicted and generally designated 500.
  • the system 500 may include a PCB assembly 510, a MIR detector 530, a filter wheel 532, a heating and/or cooling element 556, a thermally conductive plate 554, and a transmission window structure 552.
  • the components of the system 500 may be attached, or otherwise held in place, by a metal base 520.
  • the metal base 520 may be made of a thermally conductive material such as aluminum.
  • Metal base plate 520 may further be coupled to a housing 512 that may enclose inner components of the system 500.
  • the components of the system 500 may be powered by a battery 522 held in place by a battery cover 524.
  • the battery 522 is a rechargeable lithium ion rechargeable type battery.
  • the PCB assembly 510 may include pre-amplifiers, microprocessors, transmitters, receivers, and any other electrical components to implement a controller, e.g., the controller 1 10.
  • the MIR detector 530 may be coupled to the PCB assembly and may be positioned above the filter wheel 532.
  • the MIR detector 530 may include a thermopile sensor as well as a germanium or silicon lens.
  • the filter wheel 532 may include a plurality of cavities 534 defined therein.
  • the plurality of cavities 534 may hold a plurality of filters.
  • the plurality of cavities 534 may hold a first filter that passes light in a first wavelength band where a substance affects MIR emission or absorption while blocking light that is not within the first wavelength band.
  • the plurality of cavities 534 may further hold a second filter that passes light in a second wavelength band where the substance has no or negligible effect on MIR emission or absorption while blocking light that is not within the second wavelength band.
  • one or more of the plurality of cavities may hold a blackbody device to be used as a reference to stabilize continuous or non-continuous measurements of the MIR detector 530.
  • the filters within the filter wheel 532 may be configured such that a line of sight of the MIR detector 530 is selectively aligned with one of the filters or the blackbody device as the filter wheel 532 rotates.
  • Motor 514 may contact a periphery of filter wheel 532 to rotate it.
  • the thermally conductive plate 554 may retain the transmission window structure 552. Together, the thermally conductive plate 554 and the transmission window structure 552 may form a surface that may contact a surface of a body during operation of the system 500. To that end, an outer surface of the transmission window structure 552 may be aligned with an outer surface of the thermally conductive plate 554 along a single plane outside the housing 512.
  • the heating and/or cooling element 556 may have a ring shape and may be coupled to the thermally conductive plate 554.
  • the thermally conductive plate includes aluminum or an aluminum alloy.
  • the heating and/or cooling element 556 may include an aperture defined therein for MIR light to pass through.
  • a heatsink 557 may be coupled to the heating and/or cooling element to control the temperature and to provide a temperature differential.
  • the filter wheel 532 may include fan blades to create an air flow in contact with the heatsink 557.
  • the heating and/or cooling element may be a Peltier element.
  • the plurality of cavities 534 of the filter wheel 530 may be have an arcuate shape (e.g., a curved or bow shape).
  • the arcuate shape may enable multiple
  • the filter wheel 532 may rotate at about 20 rotations per minute (RPMs). At this speed, between five and six measurements may be taken through each filter held by the plurality of cavities 534. Further, during the measurements, the thermally conductive plate 552 may cool and/or warm the surface of the body at approximately 60 second cycles and amplitude of approximately 1 degree Kelvin.
  • FIG. 6 an embodiment of another window assembly for the system of FIG. 5 is depicted and generally designated 600.
  • window 610 is directly attached to the Peltier element 620 without a metal interface.
  • 640 is a thermal insulating plastic case so the heat transfer from the window to other substances, except the skin, is minimal.
  • a heat sink 630 is attached for keeping the temperature of the Peltier's upper plate at room ambient temperature.
  • the heat sink may be made of aluminum or copper.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La présente invention concerne un procédé d'analyse de concentration de substance qui comprend le calcul d'une différence pour le temps particulier entre une première quantité mesurée de rayonnement infrarouge moyen (MIR) absorbé par ou émis depuis un corps à une première longueur d'onde et une deuxième quantité mesurée de rayonnement MIR absorbée ou émise par le corps à une deuxième longueur d'onde, le calcul d'un quotient comprenant un dividende sur la base de la différence divisée par un diviseur sur la base d'une valeur dT/dt, et le calcul de la concentration de la substance dans le corps sur la base d'une corrélation avec le quotient.
PCT/US2017/042675 2016-07-18 2017-07-18 Procédés et appareils d'analyse de concentration de substance WO2018017617A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP17751514.5A EP3484365B1 (fr) 2016-07-18 2017-07-18 Procédés et appareils d'analyse de concentration de substance
CN201780046715.2A CN109561857B (zh) 2016-07-18 2017-07-18 物质浓度分析设备

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662363721P 2016-07-18 2016-07-18
US62/363,721 2016-07-18
US15/653,428 US10588552B2 (en) 2014-06-19 2017-07-18 Substance concentration analysis methods and apparatuses
US15/653,428 2017-07-18

Publications (1)

Publication Number Publication Date
WO2018017617A1 true WO2018017617A1 (fr) 2018-01-25

Family

ID=59582008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/042675 WO2018017617A1 (fr) 2016-07-18 2017-07-18 Procédés et appareils d'analyse de concentration de substance

Country Status (1)

Country Link
WO (1) WO2018017617A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900632A (en) 1997-03-12 1999-05-04 Optiscan Biomedical Corporation Subsurface thermal gradient spectrometry
WO2003045233A1 (fr) * 2001-11-21 2003-06-05 Optiscan Biomedical Corporation Procede et dispositif pour ameliorer la precision de mesures de concentration d'analyte a des sites de ponction autres que le doigt (ast)
US20150366490A1 (en) * 2014-06-19 2015-12-24 Glucovista, Inc. Substance Concentration Monitoring Apparatuses and Methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900632A (en) 1997-03-12 1999-05-04 Optiscan Biomedical Corporation Subsurface thermal gradient spectrometry
WO2003045233A1 (fr) * 2001-11-21 2003-06-05 Optiscan Biomedical Corporation Procede et dispositif pour ameliorer la precision de mesures de concentration d'analyte a des sites de ponction autres que le doigt (ast)
US20150366490A1 (en) * 2014-06-19 2015-12-24 Glucovista, Inc. Substance Concentration Monitoring Apparatuses and Methods

Similar Documents

Publication Publication Date Title
EP3157428B1 (fr) Appareil et procédés de surveillance de concentration de substance
US20200214607A1 (en) Substance Concentration Analysis Methods and Apparatuses
US6198949B1 (en) Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue
US6931328B2 (en) Analyte detection system with software download capabilities
US6825044B2 (en) Method for adjusting a blood analyte measurement
US7009180B2 (en) Pathlength-independent methods for optically determining material composition
JP5752796B2 (ja) 体内物質の濃度を非侵襲的に分析する方法
US20040132171A1 (en) Wearable device for measuring analyte concentration
EP3484365B1 (fr) Procédés et appareils d'analyse de concentration de substance
WO2018017617A1 (fr) Procédés et appareils d'analyse de concentration de substance
CA2469895A1 (fr) Procede spectroscopique permettant de determiner une concentration d'analytes dans un echantillon
EP3270783A1 (fr) Correction de mesures non effractives de signal de la concentration d'une substance
CN207721811U (zh) 一种无创血糖检测装置
US10376189B2 (en) Substance concentration correction systems and methods
UA23521U (en) Device for measuring of radiant flux of the heated surface in the infrared region of spectrum

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17751514

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2017751514

Country of ref document: EP

Effective date: 20190218